Phase II clinical trial comparing efficacy of low nicotine cigarettes (X-22) with varenicline and nicotine replacement therapies (patches, lozenges)
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2015
At a glance
- Drugs Nicotine (Primary) ; Nicotine replacement therapy; Varenicline
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Sponsors Pfizer
- 22 Jun 2015 New trial record
- 17 Jun 2015 Results published in a 22nd Century Group Media Release.
- 17 Jun 2015 As per a 22nd Century Group media release, data from this study has been accepted by Nicotine and Tobacco research for publication.